"This agreement reflects our shared responsibility to support people living with MS," said Dimitri Gitas, Country President, Novartis Canada "Through this partnership, we're strengthening support for ...

Teva Canada Limited (Teva Canada) is announcing a new commercialization and supply agreement with Novartis Pharmaceuticals ...

A small study found MS patients reported improved quality of life and reduced depression after Ocrelizumab biosimilar treatment ...

TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the upcoming schedule of presentations highlighting BRIUMVI ® (ublituximab-xiiy), to be presented (ACTRIMS) annual forum, being held February 5 – ...

The "Molecular Switch Targeting Therapies Market Landscape, Innovation Pipeline and Commercial Impact 2026" report has been added to ResearchAndMarkets.com's offering. The report is designed to give ...

Hayter was caught at Dublin Airport. A man who was caught importing just under €750,000 worth of cannabis into Ireland has been jailed for four years. Michael Hayter (40) of Marine Street, Abergavenny ...

By Ludwig Burger FRANKFURT, Jan 29 (Reuters) - Roche's adjusted operating income rose by a lower-than-expected 5% in 2025 as ...

Swiss pharma giant Roche Holding AG's RHHBY 2025 results were affected by currency headwinds. Sales totaled $74.4 billion, ...

The Canadian biotechnology firm Bionxt Solutions has reported encouraging preclinical results for its proprietary drug delivery system. The company’s oral thin film (ODF) formulation of Cladribin, an ...

The drugmaker's full-year results didn't seem to move the needle for investors who are instead focused on future growth ...

Just under €212m was spent on Ozempic and Saxenda under the medical card, Drugs Payment Scheme and Long-Term Illness schemes in two years and eight months ...

From life-saving vaccines to advanced cancer therapies, biopharmaceuticals are quietly transforming modern medicine. Made ...